These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9746469)

  • 41. Pharmacology of cardiac potassium channels.
    Li GR; Dong MQ
    Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outward currents in hypertrophied feline ventricular myocytes.
    Kleiman RB; Houser SR
    Prog Clin Biol Res; 1990; 334():65-83. PubMed ID: 2155436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in extracellular K+ concentration modulate contractility of rat and rabbit cardiac myocytes via the inward rectifier K+ current IK1.
    Bouchard R; Clark RB; Juhasz AE; Giles WR
    J Physiol; 2004 May; 556(Pt 3):773-90. PubMed ID: 14990678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts.
    Koumi S; Backer CL; Arentzen CE; Sato R
    J Clin Invest; 1995 Dec; 96(6):2870-81. PubMed ID: 8675658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of lowering arterial pressure on maximal coronary flow with and without regression of cardiac hypertrophy.
    Canby CA; Tomanek RJ
    Am J Physiol; 1989 Oct; 257(4 Pt 2):H1110-8. PubMed ID: 2529781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Voltage dependence of ATP-dependent K+ current in rat cardiac myocytes is affected by IK1 and IK(ACh).
    Wellner-Kienitz MC; Bender K; Rinne A; Pott L
    J Physiol; 2004 Dec; 561(Pt 2):459-69. PubMed ID: 15459245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azimilide inhibits multiple cardiac potassium currents in human atrial myocytes.
    Chen F; Esmailian F; Sun W; Wetzel GT; Sarma JS; Singh BN; Klitzner TS
    J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):255-64. PubMed ID: 12490972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in the Ca2+-activated K+ channels of the coronary artery during left ventricular hypertrophy.
    Kim N; Chung J; Kim E; Han J
    Circ Res; 2003 Sep; 93(6):541-7. PubMed ID: 12907665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of captopril on the development of left ventricular hypertrophy in rabbits with aortic insufficiency.
    Simko F; Pechánová O; Bernátová I; Gvozdjáková A; Kucharská J; Hulín I; Bada V; Turcáni M
    Physiol Res; 1997; 46(6):419-25. PubMed ID: 9730047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced cardiac PI3Kα signalling mitigates arrhythmogenic electrical remodelling in pathological hypertrophy and heart failure.
    Yang KC; Jay PY; McMullen JR; Nerbonne JM
    Cardiovasc Res; 2012 Feb; 93(2):252-62. PubMed ID: 22038742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophysiological effects accompanying regression of left ventricular hypertrophy.
    Botchway AN; Turner MA; Sheridan DJ; Flores NA; Fry CH
    Cardiovasc Res; 2003 Dec; 60(3):510-7. PubMed ID: 14659796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade.
    Kowey PR; Friechling TD; Sewter J; Wu Y; Sokil A; Paul J; Nocella J
    Circulation; 1991 Jun; 83(6):2067-75. PubMed ID: 1645624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potassium currents in ventricular myocytes from genetically diabetic rats.
    Tsuchida K; Watajima H
    Am J Physiol; 1997 Oct; 273(4):E695-700. PubMed ID: 9357797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spatial variability in T-tubule and electrical remodeling of left ventricular epicardium in mouse hearts with transgenic Gαq overexpression-induced pathological hypertrophy.
    Tao W; Shi J; Dorn GW; Wei L; Rubart M
    J Mol Cell Cardiol; 2012 Sep; 53(3):409-19. PubMed ID: 22728217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteasome inhibition promotes regression of left ventricular hypertrophy.
    Stansfield WE; Tang RH; Moss NC; Baldwin AS; Willis MS; Selzman CH
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H645-50. PubMed ID: 18032525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of volsartan on transmural heterogeneous changes of transient outward potassium currents in hypertrophic cardiomyocytes in rabbits.
    Xiao J; Fu H; Ma Y; Li Y; Lu Z
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(5):437-40. PubMed ID: 15641686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced anisotropy of action potential conduction in left ventricular hypertrophy.
    Carey PA; Turner M; Fry CH; Sheridan DJ
    J Cardiovasc Electrophysiol; 2001 Jul; 12(7):830-5. PubMed ID: 11469438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Function of the CaMKII-ryanodine receptor signaling pathway in rabbits with left ventricular hypertrophy and triggered ventricular arrhythmia.
    Ke J; Xiao X; Chen F; He L; Dai MS; Wang XP; Chen B; Chen M; Zhang CT
    World J Emerg Med; 2012; 3(1):65-70. PubMed ID: 25215041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversibility of electrophysiological changes induced by chronic high-altitude hypoxia in adult rat heart.
    Chouabe C; Amsellem J; Espinosa L; Ribaux P; Blaineau S; Mégas P; Bonvallet R
    Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1452-60. PubMed ID: 11893582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ventricular hypertrophy--physiological mechanisms.
    Vaughan Williams EM
    J Cardiovasc Pharmacol; 1986; 8 Suppl 3():S12-6. PubMed ID: 2429105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.